website logo

Acknowledgments

Declaration of Ethics:
A Declaration of Ethics statement should be included in the paper under the Acknowledgements section. Authors must declare if they have adhered to the Principles of Veterinary Medical Ethics of the AVMA. (https://www.avma.org/KB/Policies/Pages/Principles-of-Veterinary-Medical-Ethics-of-the-AVMA.aspx)

1. If your paper or presentation references the use of a compounded pharmaceutical, please be certain that you are familiar with the FDA guidelines on the use of compounded pharmaceuticals and that the product you reference is in compliance. See section below regarding papers using compounded medications or medical devices.
2. All submissions should cite levels of evidence-based medicine.

You should plan to include any ethical considerations as part of your oral presentation if your paper is accepted. 

Conflicts of Interest:
Authors are expected to disclose the nature of any financial interests they have with companies that manufacture or sell products that figure prominently in the submission or with companies that manufacture or sell competing products. (This includes ownership, employment, consultancy arrangements, or service as an officer or board member.) A Conflict-of-Interest statement should be included in the paper under the Acknowledgments section whether a conflict exists or not.

Example of COI Statement:
Conflict of Interest: Dr. John Doe has no conflict of interest. Dr. Jane Doe has served as a paid technology analyst for the venture capitalists that initiated the formation of Company ABC and served as a member of the Board of Directors of Company ABC from its inception until 2008. Company ABC is currently commercializing the use of Product XYZ. Dr. Jane Doe has also served as a paid consultant and continues to serve on the Company ABC Advisory Board. 

All authors are required to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work.

The American Association of Equine Practitioners’ (AAEP) policy requires that authors must disclose and describe the nature of any actual or potential financial and/or personal relationships they have with companies that manufacture or sell products that figure prominently in the submission or with companies that manufacture or sell competing products. (This includes ownership, employment, consultancy arrangements, or service as an officer or board member.) 

As part of the online submission process, submitting authors are required to confirm whether they or their co-authors have any actual or potential conflicts of interest to declare, and to provide details of these. It is the Submitting author’s responsibility to ensure that all authors adhere to this policy.

1. All authors listed on the paper must disclose any actual or potential conflicts of interest
2. All authors listed on the paper must disclose if no conflict exists
3. The nature of the conflict (actual or potential) needs to be described

Funding Sources:
Authors are expected to acknowledge all sources of funding or support for the work described and to disclose to the SREC any financial interest (including ownership, employment, consultancy arrangements, or service as an officer or board member) they have with companies that manufacture or sell products that figure prominently in the paper or with companies that manufacture or sell competing products. Such an interest will not necessarily influence the decision to accept or reject a submission for the program but must be included in the Acknowledgments section of the paper.